Medical Retina

The department manages conditions affecting the retina that are not amenable to surgical treatment. Non-surgical treatment options offered include laser and medications.

A wide range of conditions are currently under the care of the department, the most common of which include diabetic eye disease, retinal vein occlusion, age-related macular degeneration (AMD), polypoidal choroidal vasculopathy (PCV) and central serous retinopathy (CSR).

Other conditions managed by the department include retinal complications associated with myopia (myopic CNV), heredofamilial retinal dystrophies and myopic retinal degeneration.

The department is equipped with state-of-the-art outpatient suites and is supported by a comprehensive range of the latest imaging equipment for diagnostic and monitoring purposes.

Treatment capabilities range from full-suite laser facilities (including high-speed multispot lasers) to a quick turn-around intravitreal injection suite.

Key facts and figures

Intravitreal anti-vascular endothelial growth factor (VEGF) injections are the most commonly used therapy at the department.
More than 500 anti-VEGF injections are administered in the center annually.
The department is led by doctors who are trained in premier institutes in the country and from international centers of excellence.
The department conducts educational courses and holds events involving international faculty.